|
Search
Collections
Benchmarks
Upload document
Organization
nference Inc.
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Prevalence of “HER2 ultra-low” among patients with advanced breast cancer with historical IHC0 status.
Org:
nference Inc.,
AstraZeneca LLC,
